Identification of Biomarkers to Predict Time to Plasma HIV RNA Rebound and Post-Treatment Viral Control During an Intensively Monitored Antiretroviral Pause (IMAP)

The purpose of this study is to collect information about what happens when people pause, or temporarily stop taking, ART, and to collect blood samples from these people at frequent intervals. We will also study the safety of pausing ART under close observation.

DURATION: February 2017 - January 2021

STUDY TYPE: HIV Treatment

PHASE: N/A

DESIGN: Prospective Observational Cohort Study

STATUS: Complete

ENROLLMENT: 61

POPULATION: People living with HIV, 18 to 70 years old

NUMBER OF SITES: 18

SITE LOCATIONS: US, Thailand

NCT #: NCT03001128

RESULTS